Abstract. A summary of recent investigations of the duocarmycins is provided including the total synthesis of (+)-and ent-(-)-duocarmycin SA, the preparation and evaluation of the minimum potent pharmacophore of the alkylation subunit constituting the common pharmacophore of duocarmycin A and SA, the definition and characterization of the DNA alkylation properties of the agents and their correlation with biological properties, and studies to define the fundamental reactivity and molecular recognition principles relating the agents structure and properties.
Total Synthesis of (+)-and ent-(-)-Duocarmycin SA.10 Duocarmycin SA1 represents the newest and most potent naturally occurring member of this new structural class of agents. Because of its enhanced solvolytic stability relative to duocarmycin A, its examination has proven especially interesting. The total synthesis of (+)-and ent-(-)-duocarmycin SA which provided the necessary material for our subsequent evaluations was based on two, sequential regioselective nucleophilic substitution reactions11 of the unsymmetrical p-quinone diimide 1, Scheme 1. In addition to constituting a new synthetic strategy for the preparation of the natural or synthetic members of this growing class of agents, both enantiomers of N-BOC-DSA (6) and their immediate precursors have been made available through the approach.
Minimum Potent Pharmacophore of the Duocarmycin Alkylation Subunit.798
In early studies, the CI alkylation subunit12 was shown to constitute the common, minimum potent pharmacophore of duocarmycin A and SA, Fig. 2 . The preparation and evaluation of CI-TMI provided an exceptionally reactive agent (t%= 5.2 h, pH 7; t, = 35 s, pH 3) that displayed a DNA alkylation profile comparable to that of duocarmycin A or SA. Alkylation at the same adenine N3 sites was observed with CI-TMI but with less efficiency and less selectivity among the available alkylation sites. In the conduct of these studies, the electrophilic cyclopropane proved not to be obligatory to observation of the characteristic adenine N3 alkylation and additional electrophilic centers within structurally related agents were shown to provide an identical alkylation profile.13J4 Within this structurally simplified class of agents, From these studies, a model of the natural enantiomer DNA alkylation was reconstructed and is illustrated in Fig. 3 with high affinity alkylation site in w794 duplex DNA. The bound helical conformation of the agent complements the topological curvature and pitch of the minor groove with agent binding spanning 3.5 base-pairs in the 5'-direction from the adenine N3 alkylation site. The hydrophobic concave face of the agent is deeply imbedded in the minor groove and the polar functionality of the agent lies on the outer face of the complex. This nicely explains the requirement for the first three base-pairs of the alkylation sites to be A or T which extends less rigidly to the fourth base-pair. From these and related studies,l9-*3 we suggest that it is the simple event of the depth of minor groove penetration by the agent and steric accessibility to the adenine N3 alkylation site that are determining factors controlling the alkylation selectivity. For simple agents such as N-BOC-DSA, a single 5' A or T base is sufficient for agent accessibility to the adenine N3 alkylation site. For duocarmycin A and SA, two to three additional 5' A-T base-pairs are required for binding accessibility to the adenine N3 alkylation site. In addition to enhancing the DNA alkylation selectivity, the trimethoxyindole subunit of the duocarmycins serves to stabilize the inherently reversible nature of the alkylation reaction. We 
